{"id":"https://openalex.org/W7214733889","doi":"https://doi.org/10.3389/fimmu.2026.1965459","title":"Case Report: CD20/BCMA bispecific CAR-T therapy for progressive multiple sclerosis","display_name":"Case Report: CD20/BCMA bispecific CAR-T therapy for progressive multiple sclerosis","publication_year":2026,"publication_date":"2026-09-29","ids":{"openalex":"https://openalex.org/W7214733889","doi":"https://doi.org/10.3389/fimmu.2026.1965459","pmid":"https://pubmed.ncbi.nlm.nih.gov/42871097","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13658549"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1965459","doi":"https://doi.org/10.3389/fimmu.2026.1965459","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1965459","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1965459/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1965459/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5153434754","display_name":"Zhenfen Ling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135742","display_name":"Shanghai First People's Hospital","ror":"https://ror.org/04a46mh28","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210135742"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Zhenfen Ling","raw_affiliation_strings":["Shanghai General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai General Hospital","institution_ids":["https://openalex.org/I4210135742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100373211","display_name":"Xia Liu","orcid":"https://orcid.org/0000-0002-0180-2166","observed_orcids":["https://orcid.org/0000-0002-0180-2166"]},"institutions":[{"id":"https://openalex.org/I4210135742","display_name":"Shanghai First People's Hospital","ror":"https://ror.org/04a46mh28","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210135742"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xia Liu","raw_affiliation_strings":["Shanghai General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai General Hospital","institution_ids":["https://openalex.org/I4210135742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075079543","display_name":"Wensi Li","orcid":"https://orcid.org/0000-0003-0863-449X","observed_orcids":["https://orcid.org/0000-0003-0863-449X"]},"institutions":[{"id":"https://openalex.org/I4405267658","display_name":"Shanghai AbelZeta Ltd. (China)","ror":"https://ror.org/03rtc2j62","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267658"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wensi Li","raw_affiliation_strings":["Shanghai AbelZeta Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai AbelZeta Ltd","institution_ids":["https://openalex.org/I4405267658"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130833334","display_name":"Qingguo Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135742","display_name":"Shanghai First People's Hospital","ror":"https://ror.org/04a46mh28","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210135742"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qingguo Wang","raw_affiliation_strings":["Shanghai General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai General Hospital","institution_ids":["https://openalex.org/I4210135742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153495983","display_name":"Nu Tan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135742","display_name":"Shanghai First People's Hospital","ror":"https://ror.org/04a46mh28","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210135742"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Nu Tan","raw_affiliation_strings":["Shanghai General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai General Hospital","institution_ids":["https://openalex.org/I4210135742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076176583","display_name":"Xueying Ding","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135742","display_name":"Shanghai First People's Hospital","ror":"https://ror.org/04a46mh28","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210135742"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xueying Ding","raw_affiliation_strings":["Shanghai General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai General Hospital","institution_ids":["https://openalex.org/I4210135742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153448066","display_name":"Yunyi Zan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135742","display_name":"Shanghai First People's Hospital","ror":"https://ror.org/04a46mh28","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210135742"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yunyi Zan","raw_affiliation_strings":["Shanghai General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai General Hospital","institution_ids":["https://openalex.org/I4210135742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153498967","display_name":"Youyao Gu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267658","display_name":"Shanghai AbelZeta Ltd. (China)","ror":"https://ror.org/03rtc2j62","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267658"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Youyao Gu","raw_affiliation_strings":["Shanghai AbelZeta Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai AbelZeta Ltd","institution_ids":["https://openalex.org/I4405267658"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101414127","display_name":"Yuan Qian","orcid":"https://orcid.org/0000-0002-3728-7119","observed_orcids":["https://orcid.org/0000-0002-3728-7119"]},"institutions":[{"id":"https://openalex.org/I4405267658","display_name":"Shanghai AbelZeta Ltd. (China)","ror":"https://ror.org/03rtc2j62","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267658"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuan Qian","raw_affiliation_strings":["Shanghai AbelZeta Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai AbelZeta Ltd","institution_ids":["https://openalex.org/I4405267658"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153403991","display_name":"Xiaobing Luo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaobing Luo","raw_affiliation_strings":["AbelZeta Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbelZeta Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153432534","display_name":"Thule Trinh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thule Trinh","raw_affiliation_strings":["AbelZeta Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbelZeta Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153526519","display_name":"Yanfeng Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267658","display_name":"Shanghai AbelZeta Ltd. (China)","ror":"https://ror.org/03rtc2j62","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267658"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yanfeng Li","raw_affiliation_strings":["Shanghai AbelZeta Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai AbelZeta Ltd","institution_ids":["https://openalex.org/I4405267658"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113886889","display_name":"Xiaoteng Lv","orcid":"https://orcid.org/0000-0002-5853-4430","observed_orcids":["https://orcid.org/0000-0002-5853-4430"]},"institutions":[{"id":"https://openalex.org/I4405267658","display_name":"Shanghai AbelZeta Ltd. (China)","ror":"https://ror.org/03rtc2j62","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267658"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaoteng Lv","raw_affiliation_strings":["Shanghai AbelZeta Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai AbelZeta Ltd","institution_ids":["https://openalex.org/I4405267658"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153550272","display_name":"Minna Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267658","display_name":"Shanghai AbelZeta Ltd. (China)","ror":"https://ror.org/03rtc2j62","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267658"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Minna Wang","raw_affiliation_strings":["Shanghai AbelZeta Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai AbelZeta Ltd","institution_ids":["https://openalex.org/I4405267658"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153487332","display_name":"Qian Tan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267658","display_name":"Shanghai AbelZeta Ltd. (China)","ror":"https://ror.org/03rtc2j62","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267658"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qian Tan","raw_affiliation_strings":["Shanghai AbelZeta Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai AbelZeta Ltd","institution_ids":["https://openalex.org/I4405267658"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kevin Zhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801980284","display_name":"University of Vermont Medical Center","ror":"https://ror.org/04cewr321","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801980284"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Zhu","raw_affiliation_strings":["The University of Vermont Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Vermont Medical Center","institution_ids":["https://openalex.org/I2801980284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019269973","display_name":"Chengxiao Zheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267658","display_name":"Shanghai AbelZeta Ltd. (China)","ror":"https://ror.org/03rtc2j62","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267658"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chengxiao Zheng","raw_affiliation_strings":["Shanghai AbelZeta Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai AbelZeta Ltd","institution_ids":["https://openalex.org/I4405267658"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039757579","display_name":"Xin Yao","orcid":"https://orcid.org/0000-0002-9447-2003","observed_orcids":["https://orcid.org/0000-0002-9447-2003"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xin Yao","raw_affiliation_strings":["AbelZeta Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbelZeta Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152461333","display_name":"Judy Zhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267658","display_name":"Shanghai AbelZeta Ltd. (China)","ror":"https://ror.org/03rtc2j62","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267658"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Judy Zhu","raw_affiliation_strings":["Shanghai AbelZeta Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai AbelZeta Ltd","institution_ids":["https://openalex.org/I4405267658"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152966219","display_name":"Jiaqi Huang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiaqi Huang","raw_affiliation_strings":["AbelZeta Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbelZeta Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102278715","display_name":"Yihong Yao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yihong Yao","raw_affiliation_strings":["AbelZeta Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbelZeta Inc","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112527481","display_name":"Nan Shen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I2800570007","display_name":"Renji Hospital","ror":"https://ror.org/03ypbx660","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2800570007"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Nan Shen","raw_affiliation_strings":["Renji Hospital, Shanghai Jiao Tong University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renji Hospital, Shanghai Jiao Tong University School of Medicine","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I2800570007"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5112527481","https://openalex.org/A5153434754"],"corresponding_institution_ids":["https://openalex.org/I183067930","https://openalex.org/I2800570007","https://openalex.org/I4210135742"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1965459","last_page":"1965459"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9467999935150146,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9467999935150146,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.04569999873638153,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/secondary-progressive-multiple-sclerosis","display_name":"secondary progressive multiple sclerosis","score":0.9309999942779541},{"id":"https://openalex.org/keywords/drug-free-remission","display_name":"drug-free remission","score":0.8349999785423279},{"id":"https://openalex.org/keywords/immune-reprogramming","display_name":"immune reprogramming","score":0.8130000233650208},{"id":"https://openalex.org/keywords/ocular-motility-disorders","display_name":"eye movement disorders","score":0.7680000066757202},{"id":"https://openalex.org/keywords/bladder-and-bowel-dysfunction","display_name":"bowel and bladder dysfunction","score":0.8019999861717224},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.5609999895095825},{"id":"https://openalex.org/keywords/ataxia","display_name":"ataxia","score":0.6840000152587891}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8097000122070312},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.7397000193595886},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6897000074386597},{"id":"https://openalex.org/C2779651940","wikidata":"https://www.wikidata.org/wiki/Q54196","display_name":"Cerebrospinal fluid","level":2,"score":0.5257999897003174},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.392300009727478},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38499999046325684},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.35429999232292175},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.30959999561309814},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.296099990606308},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2816999852657318},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.274399995803833},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2606000006198883},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.26019999384880066}],"mesh":[{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018951","descriptor_name":"Antigens, CD20","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D020528","descriptor_name":"Multiple Sclerosis, Chronic Progressive","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D020528","descriptor_name":"Multiple Sclerosis, Chronic Progressive","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D020528","descriptor_name":"Multiple Sclerosis, Chronic Progressive","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2026.1965459","doi":"https://doi.org/10.3389/fimmu.2026.1965459","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1965459","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1965459/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13658549","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13658549/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13658549/pdf/fimmu-17-1965459.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:42871097","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42871097","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Case Reports"},{"id":"pmh:oai:doaj.org/article:c3b72b0e5b7f41ac9cc29bc304986891","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c3b72b0e5b7f41ac9cc29bc304986891","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1965459","doi":"https://doi.org/10.3389/fimmu.2026.1965459","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1965459","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1965459/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214733889.pdf","grobid_xml":"https://content.openalex.org/works/W7214733889.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W2006146248","https://openalex.org/W2023279481","https://openalex.org/W2105206040","https://openalex.org/W2126976131","https://openalex.org/W2777074421","https://openalex.org/W3092316673","https://openalex.org/W3204709126","https://openalex.org/W4211090999","https://openalex.org/W4388448512","https://openalex.org/W4388523074","https://openalex.org/W4389701772","https://openalex.org/W4393321268","https://openalex.org/W4412200041","https://openalex.org/W4415225597","https://openalex.org/W7165755747"],"related_works":["https://openalex.org/W4415956667","https://openalex.org/W4415225597","https://openalex.org/W4405095983","https://openalex.org/W7212374441","https://openalex.org/W4415559632","https://openalex.org/W7164174347","https://openalex.org/W6940180144","https://openalex.org/W7164527171","https://openalex.org/W4417516216","https://openalex.org/W4310114311"],"abstract_inverted_index":{"Refractory":[0],"secondary":[1],"progressive":[2],"multiple":[3,19],"sclerosis":[4],"(SPMS)":[5],"remains":[6],"an":[7,87],"area":[8],"of":[9,47],"unmet":[10],"need,":[11],"particularly":[12],"once":[13],"disability":[14],"continues":[15],"to":[16],"accumulate":[17],"despite":[18],"disease-modifying":[20],"therapies.":[21],"Two":[22],"SPMS":[23],"patients":[24],"are":[25],"reported":[26],"with":[27,86],"C-CAR168":[28,66],"treatment,":[29],"a":[30,99],"bispecific":[31,96],"CD20/BCMA":[32],"CAR-T":[33,97],"product,":[34],"achieving":[35],"12-":[36],"and":[37,51,62,78,82],"6-month":[38],"drug-free":[39],"remission.":[40],"Patient":[41,54],"001":[42],"(EDSS":[43,56],"4.0\u21923.0)":[44],"showed":[45],"improvement":[46],"oculomotor":[48],"dysfunction,":[49],"ataxia,":[50],"cognitive":[52],"impairment.":[53],"002":[55],"6.5\u21926.0)":[57],"demonstrated":[58],"halted":[59],"lower-limb":[60],"progression":[61],"relieved":[63],"bowel/bladder":[64],"dysfunction.":[65],"infiltrated":[67],"into":[68],"the":[69],"cerebrospinal":[70],"fluid":[71],"(CSF),":[72],"persistently":[73],"depleted":[74],"pathogenic":[75],"B-lineage":[76],"cells":[77],"CD20dim":[79],"T":[80],"cells,":[81],"normalized":[83],"inflammatory":[84],"markers":[85],"overall":[88],"favorable":[89],"safety":[90],"profile.":[91],"This":[92],"first-in-human":[93],"experience":[94],"supports":[95],"as":[98],"promising":[100],"immune-reprogramming":[101],"strategy":[102],"for":[103],"refractory":[104],"SPMS.":[105]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-09-30T00:00:00"}